Gene editing enhances immunotherapy success by preventing T-cell exhaustion

Immunotherapy, using a patient’s own immune system to treat disease, has shown promise in some patients with cancer but has not worked in most.

Enzalutamide by Pfizer for Fallopian Tube Cancer: Likelihood of Approval

Share this article GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug

December 24, 2023

Study sheds light on how cold temperatures affect appetite

Neuroscientists at Scripps Research have identified brain circuits that make mammals want to eat more when they are exposed to cold temperatures.

August 17, 2023

After decades in use, heart stents finally beat placebo. It took a bold researcher

PHILADELPHIA — A new study, and the bold doctor who led it, could result in big questions about how researchers study medical devices and surgical

November 11, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.